{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T10:20:34Z","timestamp":1782296434344,"version":"3.54.5"},"update-to":[{"DOI":"10.1002\/14651858.cd011605","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2016,10,11]],"date-time":"2016-10-11T00:00:00Z","timestamp":1476144000000}}],"reference-count":95,"publisher":"Wiley","issue":"5","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd011605.pub2","type":"journal-article","created":{"date-parts":[[2016,10,13]],"date-time":"2016-10-13T16:30:23Z","timestamp":1476376223000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Fentanyl for neuropathic pain in adults"],"prefix":"10.1002","volume":"2019","author":[{"given":"Sheena","family":"Derry","sequence":"first","affiliation":[{"name":"Oxford Oxfordshire UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathy","family":"Stannard","sequence":"additional","affiliation":[{"name":"NHS Gloucestershire CCG; Sanger House, 5220 Valiant Court Gloucester Business Park Brockworth UK GL3 4FE"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Cole","sequence":"additional","affiliation":[{"name":"Churchill Hospital, Oxford University Hospitals NHS Trust; Oxford Pain Relief Unit; Old Road Headington Oxford UK OX3 7LE"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip J","family":"Wiffen","sequence":"additional","affiliation":[{"name":"Thame UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Knaggs","sequence":"additional","affiliation":[{"name":"University of Nottingham; School of Pharmacy; University Park Nottingham UK NG7 2RD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic","family":"Aldington","sequence":"additional","affiliation":[{"name":"Royal Hampshire County Hospital; Winchester UK SO22 5DG"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R Andrew","family":"Moore","sequence":"additional","affiliation":[{"name":"Plymouth UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,10,11]]},"reference":[{"issue":"12","key":"10.1002\/14651858.CD011605.pub2-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1185\/03007995.2015.1092127","article-title":"Two placebo-controlled, randomized withdrawal studies to evaluate the fentanyl 1 day patch in opioid-na\u00efve patients with chronic pain","volume":"31","author":"Arai","year":"2015","journal-title":"Current Medical Research and Opinion"},{"key":"10.1002\/14651858.CD011605.pub2-BIB0002|cit2","unstructured":"Janssen Pharmaceutical KK (Sponsors) A confirmatory study of fentanyl in participants with post-herpetic neuralgia, complex regional pain syndrome or postoperative pain syndrome clinicaltrials.gov\/ct2\/show\/record\/NCT01008553"},{"issue":"8","key":"10.1002\/14651858.CD011605.pub2-BIB0003|cit3","first-page":"871","article-title":"Safety and efficacy of transdermal buprenorphine and transdermal fentanyl in the treatment of neuropathic pain in AIDS patients","volume":"79","author":"Canneti","year":"2013","journal-title":"Minerva Anestesiologica"},{"key":"10.1002\/14651858.CD011605.pub2-BIB0004|cit4","first-page":"1307","article-title":"Assessment of transdermal fentanyl combined with gabapentin for malignant neuropathic pain treatment. [Chinese]","volume":"41","author":"Ding","year":"2014","journal-title":"Chinese Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD011605.pub2-BIB0005|cit5","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1741-7015-5-39","article-title":"Predicting long-term response to strong opioids in patients with low back pain: findings from a randomized, controlled trial of transdermal fentanyl and morphine","volume":"5","author":"Kalso","year":"2007","journal-title":"BMC Medicine"},{"key":"10.1002\/14651858.CD011605.pub2-BIB0006|cit6","unstructured":"NCT01127100 Gabapentin versus transdermal fentanyl matrix for chronic neuropathic pain clinicaltrials.gov\/ct2\/show\/NCT01127100"},{"issue":"1","key":"10.1002\/14651858.CD011605.pub2-BIB0007|cit7","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s00701-010-0785-4","article-title":"Evaluation of efficacy and safety of fentanyl transdermal patch (Durogesic D-TRANS) in chronic pain","volume":"153","author":"Park","year":"2011","journal-title":"Acta Neurochirurgica (Wien)"},{"issue":"7","key":"10.1002\/14651858.CD011605.pub2-BIB0008|cit8","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1111\/j.1526-4637.2006.00246.x","article-title":"Transdermal fentanyl reduces pain and improves functional activity in neuropathic pain states","volume":"8","author":"Agarwal","year":"2007","journal-title":"Pain Medicine"},{"issue":"7295","key":"10.1002\/14651858.CD011605.pub2-BIB0009|cit9","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1136\/bmj.322.7295.1154","article-title":"Randomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain","volume":"322","author":"Allan","year":"2001","journal-title":"BMJ"},{"issue":"22","key":"10.1002\/14651858.CD011605.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1097\/01.brs.0000186860.23078.a8","article-title":"Transdermal fentanyl versus sustained release oral morphine in strong-opioid na\u00efve patients with chronic low back pain","volume":"30","author":"Allan","year":"2005","journal-title":"Spine (Phila Pa 1976)"},{"issue":"8","key":"10.1002\/14651858.CD011605.pub2-BIB0011|cit11","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/S1474-4422(10)70143-5","article-title":"Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment","volume":"9","author":"Baron","year":"2010","journal-title":"Lancet Neurology"},{"issue":"1","key":"10.1002\/14651858.CD011605.pub2-BIB0012|cit12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S1474-4422(11)70281-2","article-title":"Chronic pain: genes, plasticity, and phenotypes","volume":"11","author":"Baron","year":"2012","journal-title":"Lancet Neurology"},{"issue":"3","key":"10.1002\/14651858.CD011605.pub2-BIB0013|cit13","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.pain.2007.08.013","article-title":"Prevalence of chronic pain with neuropathic characteristics in the general population","volume":"136","author":"Bouhassira","year":"2008","journal-title":"Pain"},{"issue":"21","key":"10.1002\/14651858.CD011605.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/0024-3205(84)90369-2","article-title":"A novel form of dependency of hepatic extraction ratio of opioids in vivo upon the portal vein concentration of drug: comparison of morphine, diamorphine, fentanyl, methadone and buprenorphine in the chronically cannulated cow","volume":"34","author":"Bullingham","year":"1984","journal-title":"Life Sciences"},{"issue":"1","key":"10.1002\/14651858.CD011605.pub2-BIB0015|cit15","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1097\/SPC.0b013e3283437a39","article-title":"Transdermal opioids for cancer pain","volume":"5","author":"Cachia","year":"2011","journal-title":"Current Opinion in Supportive and Palliative Care"},{"issue":"4","key":"10.1002\/14651858.CD011605.pub2-BIB0016|cit16","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/S0885-3924(98)00070-0","article-title":"Prolonged treatment with transdermal fentanyl in neuropathic pain","volume":"16","author":"Dellemijn","year":"1998","journal-title":"Journal of Pain and Symptom Management"},{"issue":"9","key":"10.1002\/14651858.CD011605.pub2-BIB0017|cit17","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010111","article-title":"Topical capsaicin (low concentration) for chronic neuropathic pain in adults","author":"Derry","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD011605.pub2-BIB0018|cit18","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007393.pub3","article-title":"Topical capsaicin (high concentration) for chronic neuropathic pain in adults","author":"Derry","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD011605.pub2-BIB0019|cit19","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010958.pub2","article-title":"Topical lidocaine for neuropathic pain in adults","author":"Derry","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6 Suppl 63","key":"10.1002\/14651858.CD011605.pub2-BIB0020|cit20","first-page":"S110","article-title":"Pharmacological treatment of fibromyalgia","volume":"28","author":"Franco","year":"2010","journal-title":"Clinical and Experimental Rheumatology"},{"issue":"2","key":"10.1002\/14651858.CD011605.pub2-BIB0021|cit21","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jpain.2007.09.005","article-title":"Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations","volume":"9","author":"Dworkin","year":"2008","journal-title":"Journal of Pain"},{"issue":"2","key":"10.1002\/14651858.CD011605.pub2-BIB0022|cit22","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(14)70251-0","article-title":"Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis","volume":"14","author":"Finnerup","year":"2015","journal-title":"Lancet Neurology"},{"issue":"2","key":"10.1002\/14651858.CD011605.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1163\/156856902760196315","article-title":"Usefulness of transdermal fentanyl in the management of nonmalignant chronic pain: A prospective, observational, multicenter study","volume":"14","author":"Franco","year":"2002","journal-title":"Pain Clinic"},{"issue":"14","key":"10.1002\/14651858.CD011605.pub2-BIB0024|cit24","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1212\/WNL.0000000000000839","article-title":"Opioids for chronic noncancer pain: a position paper of the American Academy of Neurology","volume":"83","author":"Franklin","year":"2014","journal-title":"Neurology"},{"issue":"6","key":"10.1002\/14651858.CD011605.pub2-BIB0025|cit25","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010692.pub2","article-title":"Oxycodone for neuropathic pain and fibromyalgia in adults","author":"Gaskell","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD011605.pub2-BIB0026|cit26","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/j.1399-6576.2007.01486.x","article-title":"Prevalence of self-reported neuropathic pain and impact on quality of life: a prospective representative survey","volume":"52","author":"Gustorff","year":"2008","journal-title":"Acta Anaesthesiologica Scandinavica"},{"issue":"12","key":"10.1002\/14651858.CD011605.pub2-BIB0027|cit27","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.jclinepi.2011.03.017","article-title":"GRADE guidelines: 7. Rating the quality of evidence - inconsistency","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD011605.pub2-BIB0028|cit28","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jclinepi.2012.01.006","article-title":"GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes","volume":"66","author":"Guyatt","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD011605.pub2-BIB0029|cit29","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jclinepi.2012.01.012","article-title":"GRADE guidelines: 12. Preparing summary of findings tables-binary outcomes","volume":"66","author":"Guyatt","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD011605.pub2-BIB0030|cit30","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1471-2296-9-26","article-title":"Primary care incidence and treatment of four neuropathic pain conditions: a descriptive study, 2002-2005","volume":"9","author":"Hall","year":"2008","journal-title":"BMC Family Practice"},{"key":"10.1002\/14651858.CD011605.pub2-BIB0031|cit31","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1471-2296-14-28","article-title":"An observational descriptive study of the epidemiology and treatment of neuropathic pain in a UK general population","volume":"14","author":"Hall","year":"2013","journal-title":"BMC Family Practice"},{"issue":"1-2","key":"10.1002\/14651858.CD011605.pub2-BIB0032|cit32","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.pain.2009.04.012","article-title":"Transdermal fentanyl in cachectic cancer patients","volume":"144","author":"Heiskanen","year":"2009","journal-title":"Pain"},{"key":"10.1002\/14651858.CD011605.pub2-BIB0033|cit33","unstructured":"Higgins JPT Green S editor(s) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"2","key":"10.1002\/14651858.CD011605.pub2-BIB0034|cit34","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.pain.2009.09.017","article-title":"How do changes in pain severity levels correspond to changes in health status and function in patients with painful diabetic peripheral neuropathy?","volume":"149","author":"Hoffman","year":"2010","journal-title":"Pain"},{"issue":"1","key":"10.1002\/14651858.CD011605.pub2-BIB0035|cit35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD011605.pub2-BIB0036|cit36","doi-asserted-by":"crossref","unstructured":"Jensen TS Baron R Haanp\u00e4\u00e4 M Kalso E Loeser JD Rice AS A new definition of neuropathic pain Pain 2011 2204 5 10.1016\/j.pain.2011.06.017","DOI":"10.1016\/j.pain.2011.06.017"},{"key":"10.1002\/14651858.CD011605.pub2-BIB0037|cit37","doi-asserted-by":"publisher","first-page":"f7339","DOI":"10.1136\/bmj.f7339","article-title":"Drugs for neuropathic pain","volume":"347","author":"Kalso","year":"2013","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD011605.pub2-BIB0038|cit38","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1159\/000110284","article-title":"Epidemiology and clinical features of idiopathic trigeminal neuralgia and glossopharyngeal neuralgia: similarities and differences, Rochester, Minnesota,1945-1984","volume":"10","author":"Katusic","year":"1991","journal-title":"Neuroepidemiology"},{"issue":"1-3","key":"10.1002\/14651858.CD011605.pub2-BIB0039|cit39","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.pain.2009.08.023","article-title":"Incidence of facial pain in the general population","volume":"147","author":"Koopman","year":"2009","journal-title":"Pain"},{"key":"10.1002\/14651858.CD011605.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"224","DOI":"10.7326\/0003-4819-107-2-224","article-title":"Meta-analysis in clinical research","volume":"107","author":"L'Abb\u00e9","year":"1987","journal-title":"Annals of Internal Medicine"},{"issue":"6","key":"10.1002\/14651858.CD011605.pub2-BIB0041|cit41","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s12325-010-0036-3","article-title":"Efficacy and safety of tapentadol prolonged release for chronic osteoarthritis pain and low back pain","volume":"27","author":"Lange","year":"2010","journal-title":"Advances in Therapy"},{"issue":"1","key":"10.1002\/14651858.CD011605.pub2-BIB0042|cit42","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007115.pub3","article-title":"Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia","author":"Lunn","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD011605.pub2-BIB0043|cit43","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s40262-012-0016-7","article-title":"Pharmacokinetics of non-intravenous formulations of fentanyl","volume":"52","author":"L\u00f6tsch","year":"2013","journal-title":"Clinical Pharmacokinetics"},{"issue":"8","key":"10.1002\/14651858.CD011605.pub2-BIB0044|cit44","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006146.pub2","article-title":"Opioids for neuropathic pain","author":"McNicol","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD011605.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/bja\/51.6.543","article-title":"Plasma fentanyl concentrations and clinical observations during and after operation","volume":"51","author":"McQuay","year":"1979","journal-title":"British Journal of Anaesthesia"},{"key":"10.1002\/14651858.CD011605.pub2-BIB0046|cit46","volume-title":"An Evidence-Based Resource for Pain Relief","author":"McQuay","year":"1998"},{"key":"10.1002\/14651858.CD011605.pub2-BIB0047|cit47","first-page":"519","article-title":"Chronic pain","volume-title":"Health Care Needs Assessment, 3rd Series","author":"McQuay","year":"2007"},{"issue":"4","key":"10.1002\/14651858.CD011605.pub2-BIB0048|cit48","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1054\/jpai.2001.25352","article-title":"Evaluation of long-term efficacy and safety of transdermal fentanyl in the treatment of chronic noncancer pain","volume":"2","author":"Milligan","year":"2001","journal-title":"Journal of Pain"},{"key":"10.1002\/14651858.CD011605.pub2-BIB0049|cit49","unstructured":"Mitra F Chowdhury S Williams G Shelley M Comparison of transdermal fentanyl and buprenorphine on clinical outcomes, acceptability and side-effects on prospective one-year follow-up of long-term persistent pain patients Australian Pain Society Conference DArwin, NT Australia Australian Society of Anaesthetists 2011 747 8"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD011605.pub2-BIB0050|cit50","doi-asserted-by":"publisher","first-page":"S80","DOI":"10.1016\/j.neuroimage.2007.03.054","article-title":"Brain imaging of neuropathic pain","volume":"37","author":"Moisset","year":"2007","journal-title":"Neuroimaging"},{"issue":"3","key":"10.1002\/14651858.CD011605.pub2-BIB0051|cit51","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0304-3959(98)00140-7","article-title":"Size is everything - large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects","volume":"78","author":"Moore","year":"1998","journal-title":"Pain"},{"key":"10.1002\/14651858.CD011605.pub2-BIB0052|cit52","first-page":"15","article-title":"Managing potential publication bias","volume-title":"Systematic Reviews in Pain Research: Methodology Refined","author":"Moore","year":"2008"},{"issue":"3","key":"10.1002\/14651858.CD011605.pub2-BIB0053|cit53","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007076.pub2","article-title":"Pregabalin for acute and chronic pain in adults","author":"Moore","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD011605.pub2-BIB0054|cit54","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.pain.2010.05.011","article-title":"\"Evidence\" in chronic pain - establishing best practice in the reporting of systematic reviews","volume":"150","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"3","key":"10.1002\/14651858.CD011605.pub2-BIB0055|cit55","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.pain.2010.02.032","article-title":"Chronic low back pain analgesic studies - a methodological minefield","volume":"149","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"2","key":"10.1002\/14651858.CD011605.pub2-BIB0056|cit56","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.pain.2010.02.039","article-title":"Fibromyalgia: moderate and substantial pain intensity reduction predicts improvement in other outcomes and substantial quality of life gain","volume":"149","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"3","key":"10.1002\/14651858.CD011605.pub2-BIB0057|cit57","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.pain.2010.07.013","article-title":"Numbers-needed-to-treat analyses - do timing, dropouts, and outcome matter? Pooled analysis of two randomized, placebo-controlled chronic low back pain trials","volume":"151","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"2","key":"10.1002\/14651858.CD011605.pub2-BIB0058|cit58","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1136\/ard.2009.107805","article-title":"Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice","volume":"69","author":"Moore","year":"2010","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"5","key":"10.1002\/14651858.CD011605.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.pain.2010.11.030","article-title":"Minimum efficacy criteria for comparisons between treatments using individual patient meta-analysis of acute pain trials: examples of etoricoxib, paracetamol, ibuprofen, and ibuprofen\/paracetamol combinations after third molar extraction","volume":"152","author":"Moore","year":"2011","journal-title":"Pain"},{"issue":"6","key":"10.1002\/14651858.CD011605.pub2-BIB0060|cit60","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1097\/EJA.0b013e328343c569","article-title":"Mean analgesic consumption is inappropriate for testing analgesic efficacy in post-operative pain: analysis and alternative suggestion","volume":"28","author":"Moore","year":"2011","journal-title":"European Journal of Anaesthesiology"},{"issue":"12","key":"10.1002\/14651858.CD011605.pub2-BIB0061|cit61","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008242.pub2","article-title":"Amitriptyline for neuropathic pain and fibromyalgia in adults","author":"Moore","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD011605.pub2-BIB0062|cit62","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.pain.2011.10.004","article-title":"Estimate at your peril: imputation methods for patient withdrawal can bias efficacy outcomes in chronic pain trials using responder analyses","volume":"153","author":"Moore","year":"2012","journal-title":"Pain"},{"issue":"4","key":"10.1002\/14651858.CD011605.pub2-BIB0063|cit63","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1111\/anae.12148","article-title":"Pain measures and cut-offs - 'no worse than mild pain' as a simple, universal outcome","volume":"68","author":"Moore","year":"2013","journal-title":"Anaesthesia"},{"key":"10.1002\/14651858.CD011605.pub2-BIB0064|cit64","doi-asserted-by":"publisher","first-page":"f2690","DOI":"10.1136\/bmj.f2690","article-title":"Expect analgesic failure; pursue analgesic success","volume":"346","author":"Moore","year":"2013","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD011605.pub2-BIB0065|cit65","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/papr.12050","article-title":"The costs and consequences of adequately managed chronic non-cancer pain and chronic neuropathic pain","volume":"14","author":"Moore","year":"2014","journal-title":"Pain Practice"},{"issue":"4","key":"10.1002\/14651858.CD011605.pub2-BIB0066|cit66","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007938.pub3","article-title":"Gabapentin for chronic neuropathic pain and fibromyalgia in adults","author":"Moore","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD011605.pub2-BIB0067|cit67","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/j.1532-2149.2013.00341.x","article-title":"Duloxetine use in chronic painful conditions - individual patient data responder analysis","volume":"18","author":"Moore","year":"2014","journal-title":"European Journal of Pain"},{"issue":"8","key":"10.1002\/14651858.CD011605.pub2-BIB0068|cit68","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1097\/j.pain.0000000000000088","article-title":"Systematic review of enriched enrolment, randomised withdrawal trial designs in chronic pain: a new framework for design and reporting","volume":"156","author":"Moore","year":"2015","journal-title":"Pain"},{"issue":"6","key":"10.1002\/14651858.CD011605.pub2-BIB0069|cit69","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/S1526-5900(03)00632-1","article-title":"Long-term management of noncancer pain with transdermal therapeutic system-fentanyl","volume":"4","author":"Mystakidou","year":"2003","journal-title":"Journal of Pain"},{"issue":"4","key":"10.1002\/14651858.CD011605.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/BF03178274","article-title":"Transdermal fentanyl: pharmacology and toxicology","volume":"5","author":"Nelson","year":"2009","journal-title":"Journal of Medical Toxicology"},{"key":"10.1002\/14651858.CD011605.pub2-BIB0071|cit71","unstructured":"National Institute for Health and Care Excellence (NICE) Neuropathic pain - pharmacological management: the pharmacological management of neuropathic pain in adults in non-specialist settings, 2013 www.nice.org.uk\/guidance\/cg173"},{"issue":"1","key":"10.1002\/14651858.CD011605.pub2-BIB0072|cit72","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/j.1526-4637.2009.00685","article-title":"Patient-centered perspective on treatment outcomes in chronic pain","volume":"11","author":"O'Brien","year":"2010","journal-title":"Pain Medicine"},{"issue":"10 Suppl","key":"10.1002\/14651858.CD011605.pub2-BIB0073|cit73","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.1016\/j.amjmed.2009.04.007","article-title":"Treatment of neuropathic pain: an overview of recent guidelines","volume":"122","author":"O'Connor","year":"2009","journal-title":"American Journal of Medicine"},{"key":"10.1002\/14651858.CD011605.pub2-BIB0074|cit74","unstructured":"Cochrane Pain, Palliative and Supportive Care Group (PaPaS) author and referee guidance papas.cochrane.org\/papas-documents"},{"issue":"1","key":"10.1002\/14651858.CD011605.pub2-BIB0075|cit75","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s00701-010-0785-4","article-title":"Evaluation of efficacy and safety of fentanyl transdermal patch (Durogesic D-TRANS) in chronic pain","volume":"153","author":"Park","year":"2011","journal-title":"Acta Neurochirurgica (Wien)"},{"key":"10.1002\/14651858.CD011605.pub2-BIB0076|cit76","unstructured":"Prescribing and Medicines Team Health and Social Care Information Centre Prescription Cost Analysis, England 2014 content.digital.nhs.uk\/catalogue\/PUB17274\/pres-cost-anal-eng-2014-rep.pdf 119 21"},{"key":"10.1002\/14651858.CD011605.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0304-3959(94)90086-8","article-title":"Trigeminal neuralgia: the role of self-sustaining discharge in the trigeminal ganglion","volume":"56","author":"Rappaport","year":"1994","journal-title":"Pain"},{"issue":"1","key":"10.1002\/14651858.CD011605.pub2-BIB0078|cit78","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/papr.12045","article-title":"Pregabalin vs. opioids for the treatment of neuropathic cancer pain: a prospective, head-to-head, randomized, open-label study","volume":"14","author":"Raptis","year":"2014","journal-title":"Pain Practice"},{"key":"10.1002\/14651858.CD011605.pub2-BIB0079|cit79","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"issue":"7","key":"10.1002\/14651858.CD011605.pub2-BIB0080|cit80","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1002\/art.37962","article-title":"Neuropathic features of joint pain: a community-based study","volume":"65","author":"Soni","year":"2013","journal-title":"Arthritis & Rheumatism"},{"issue":"2","key":"10.1002\/14651858.CD011605.pub2-BIB0081|cit81","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/j.1365-2125.2008.03200","article-title":"Enriched enrolment: definition and effects of enrichment and dose in trials of pregabalin and gabapentin in neuropathic pain. A systematic review","volume":"66","author":"Straube","year":"2008","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD011605.pub2-BIB0082|cit82","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/1471-2474-11-150","article-title":"Pregabalin in fibromyalgia - responder analysis from individual patient data","volume":"11","author":"Straube","year":"2010","journal-title":"BMC Musculoskeletal Disorders"},{"key":"10.1002\/14651858.CD011605.pub2-BIB0083|cit83","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1471-2377-8-9","article-title":"Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials","volume":"8","author":"Sultan","year":"2008","journal-title":"BMC Neurology"},{"issue":"4","key":"10.1002\/14651858.CD011605.pub2-BIB0084|cit84","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.jpain.2005.11.008","article-title":"The epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population survey","volume":"7","author":"Torrance","year":"2006","journal-title":"Journal of Pain"},{"issue":"3","key":"10.1002\/14651858.CD011605.pub2-BIB0085|cit85","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/nrneurol.2011.4","article-title":"Can neuroimaging studies identify pain endophenotypes in humans?","volume":"7","author":"Tracey","year":"2011","journal-title":"Nature Reviews Neurology"},{"issue":"18","key":"10.1002\/14651858.CD011605.pub2-BIB0086|cit86","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1212\/01.wnl.0000282763.29778.59","article-title":"Neuropathic pain: redefinition and a grading system for clinical and research purposes","volume":"70","author":"Treede","year":"2008","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD011605.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"S133","DOI":"10.36076\/ppj.2008\/11\/S133","article-title":"Opioid pharmacology","volume":"11","author":"Trescot","year":"2008","journal-title":"Pain Physician"},{"issue":"4","key":"10.1002\/14651858.CD011605.pub2-BIB0088|cit88","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.pain.2013.11.013","article-title":"Neuropathic pain in the general population: a systematic review of epidemiological studies","volume":"155","author":"Hecke","year":"2014","journal-title":"Pain"},{"issue":"3","key":"10.1002\/14651858.CD011605.pub2-BIB0089|cit89","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.pain.2009.03.013","article-title":"Non-steroidal anti-inflammatory drugs for neuropathic pain: how do we explain continued widespread use?","volume":"143","author":"Vo","year":"2009","journal-title":"Pain"},{"issue":"4","key":"10.1002\/14651858.CD011605.pub2-BIB0090|cit90","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.neuron.2012.02.008","article-title":"Deconstructing the neuropathic pain phenotype\u00a0to reveal neural mechanisms","volume":"73","author":"Hehn","year":"2012","journal-title":"Neuron"},{"issue":"9859","key":"10.1002\/14651858.CD011605.pub2-BIB0091|cit91","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1016\/S0140-6736(12)61729-2","article-title":"Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Vos","year":"2012","journal-title":"Lancet"},{"issue":"6","key":"10.1002\/14651858.CD011605.pub2-BIB0092|cit92","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/j.drugpo.2014.07.009","article-title":"Prescription opioid misuse in the United States and the United Kingdom: cautionary lessons","volume":"25","author":"Weisberg","year":"2014","journal-title":"International Journal on Drug Policy"},{"issue":"11","key":"10.1002\/14651858.CD011605.pub2-BIB0093|cit93","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010567.pub2","article-title":"Antiepileptic drugs for neuropathic pain and fibromyalgia - an overview of Cochrane reviews","author":"Wiffen","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"9","key":"10.1002\/14651858.CD011605.pub2-BIB0094|cit94","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011603.pub2","article-title":"Buprenorphine for neuropathic pain in adults","author":"Wiffen","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"9","key":"10.1002\/14651858.CD011605.pub2-BIB0095|cit95","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1002\/j.1532-2149.2014.496.x","article-title":"Changes in trends and pattern of strong opioid prescribing in primary care","volume":"18","author":"Zin","year":"2014","journal-title":"European Journal of Pain"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD011605.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T04:01:54Z","timestamp":1688961714000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD011605.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Pain, Palliative and Supportive Care Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,10,11]]},"references-count":95,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2019,5]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd011605.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,11]]}}}